Table 1.
Demographic Data | Baseline Measurements | CST | Insulin Tolerance Test | Imaging | Therapy and Outcomes | |||||
---|---|---|---|---|---|---|---|---|---|---|
Sex | Age (Years) | Cortisol (mcg/dL) | ACTH (pg/mL) | IGF-1 (Z-score) | Peak Cortisol (mcg/dl) | Peak Cortisol (mcg/dl) | Peak GH (ng/mL) | Negative Pituitary MRI | Treatment | Symptom Improvement |
F | 25 | 1.1 | 29 | −1.65 | 16 | <1 | 0.62 | Yes | HC | Unknown |
F | 48 | 4.2 | 7.7 | 1.22 | 22 | 5.4 | 0.05 | Yes | HC | Yes |
F | 37 | 9.7 | 12 | - | 15 | 5.4 | 0.73 | Yes | HC | No |
F | 25 | 6.3 | 23 | −0.84 | 19 | 5.7 | 1.64 | No | HC | Yes |
M | 56 | 6.9 | 26 | 0.67 | 7.2 | 3.83 | Yes | HC | Unknown | |
F | 22 | 5.7 | 12 | −1.04 | 18 | 7.5 | 12 | Yes | HC | Unknown |
F | 43 | 9.4 | 54 | 0.13 | 8.1 | 0.22 | Yes | HC, GH | Unknown | |
F | 61 | 9.1 | 13 | −1.37 | 20 | 8.1 | 0.15 | Yes | HC | Yes |
F | 39 | 6.5 | 14 | −1.13 | 19 | 8.4 | 0.27 | Yes | HC | Unknown |
F | 39 | 8.5 | 36 | 1.70 | 8.5 | 3.7 | Yes | HC | Yes | |
F | 34 | 11 | 19 | −1.96 | 10 | 0.5 | Yes | HC, GH | Unknown | |
F | 53 | 7.3 | 20 | 0.84 | 20 | 11 | 0.06 | Yes | HC, GH | Yes to HC, no to GH |
F | 47 | 9.3 | 8 | – | 22 | 11 | 4.9 | Yes | Pred | No |
F | 21 | 11 | 17 | – | 11 | 0.26 | Yes | HC | Unknown | |
M | 32 | 11 | 10 | 1.08 | 11 | 0.07 | Yes | HC | Unknown | |
F | 41 | 4 | 8.6 | −0.17 | 12 | 0.36 | Yes | HC | No | |
M | 32 | 5.7 | 34 | −0.84 | 26 | 13 | 0.03 | Yes | HC, GH | Unknown |
F | 65 | 6.8 | 9.6 | −1.82 | 26 | 14 | 0.69 | Yes | HC | Yes |
F | 39 | 11 | 13 | −1.71 | 14 | 14 | – | Yes | HC | No |
F | 19 | 9.1 | 9.2 | −1.04 | 23 | 17 | 1.37 | Yes | HC | yes |
M | 26 | 8.7 | 19 | −1.82 | 29 | 17 | 0.06 | Yes | HC, GH | No to HC, yes to GH |
F | 25 | 11 | 21 | – | 17 | 3.68 | No | HC | Yes |
Abbreviations: CST, cosyntropin stimulation test; HC, hydrocortisone; GH, growth hormone; Pred, prednisone; MRI, magnetic resonance imaging.